Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +570.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed -32.6% from the comparable as-filed period.
Total assets changed +60.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -23.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating margin changed -2261 basis points from the comparable as-filed period.
Operating cash flow changed -20.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed +202.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed +17.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Shares outstanding changed -71.5% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
Current assets changed +131.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed +490 basis points from the comparable as-filed period.
Stock-based compensation changed +270.9% from the comparable as-filed period.
Inventory changed +87.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
SBC / revenue changed +3529 basis points from the comparable as-filed period.
Selling, general & administrative changed +29.1% from the comparable as-filed period.
Revenue changed +19.0% from the comparable as-filed period.
Working capital changed +228.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Research & development changed +16.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current ratio changed +123.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital / assets changed +3490 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Free-cash-flow margin changed -828 basis points from the comparable as-filed period.
Operating cash-flow margin changed -339 basis points from the comparable as-filed period.
Inventory / revenue changed +199 basis points from the comparable as-filed period.
Current liabilities changed +3.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -59 basis points from the comparable as-filed period.
Short-term borrowings changed +0.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.